[HeidelbergScience]

6 - Even though this method claims that only picograms of material are needed, you need hundreds ng/few ug of tot RNA to start with, due to losses in extraction, column purification, fragmentation, purification again…And then it can sequence all the RNA species…yes, but if I would simply do a Ribozero treatment (or a “home-brewed” version of it. There are some around) on as little as 10 ng + SMARTer (or SMART-seq2) I would achieve the same result with the same or less effort!

One can use 10 ng of total RNA input, enrich it for mRNA via poly(dT) magnetic beads and fragment with Mg2+, yielding approx. 100-300 pg of 20-100 bp RNA in 40 µl eluate. The important thing here is to add 10 µg of glycogen as a co-precipitant during clean-up step (with miRNAeasy kit). In our hands, the whole procedure of sample preparation (before polyA-tailing) takes about 1 hour. Subsequently one could set-up a poly(A) reaction in 50 µl and, than concentrate the whole 50 µl (e.g. via Zymo columns or EtOH precipitation). Even 10 pg of fragmented RNA is already enough for CATS (the protocol posted on this forum) to generate high complexity libraries for mRNA-seq. There are also many other options to fragment RNA (including thermosensitive RNAses) w/o the need to subsequently purify and concentrate the sample.

However, if we speak about mRNA-seq from ultra-low (1-100) number of cells, then SMART-seq is probably the most convenient way (and Ribozero would not be even necessary). However, most researchers are working with much higher number of cells (e.g. growing on 96 - 24well plates), from where obtaining 100-1000 ng of RNA is not a problem. After ~30 min procedure of poly(A)-enrichment, one can get 3 – 30 ng of mRNA in 40 µl eluate, and run CATS even without a need to concentrate the polyadenylated product before RT. Also, unlike SMART-seq, CATS gives (1) strand-specific information about mRNA and (2) has even coverage along all mRNAs. While:

(1) SMART-based mRNA-seq is not strand specific.

(2) with SMART-seq 5’-proximal and 3’-proximal parts of mRNAs are likely to be significantly underrepresented due to the inevitable premature template switching and taqmentation bias. Please correct us if we are wrong.

(3) SMART-seq is limited only to mRNA-sequencing; while CATS allows any RNA-seq, including small (20-200nt) RNA, like RIP-samples, miRNA, piRNA etc, and also any DNA-seq. So it is a universal protocol.

(4) SMART-seq would actually require more efforts because “RT and template switch” there is used only to generate and pre-amplify long cDNAs from mRNA. The library preparation itself occurs afterwards via fragmentation/adaptors ligation or taqmentation and further pre-amplification + purification. It is much easier to do mRNA enrichment (30 min), fragmentation/cleanup (20 min) and CATS (4-5 hours total, 20 min hands-on time).

To summarize, if you have a few cells and require only mRNA-seq than SMART-seq is the probably the best option. However, one can still convert mRNA from a single-cell into cDNA using poly(dT) primers, and run CATS after genome-wide DNA pre-amplification till hundred picograms.

[HeidelbergScience]

7 - You always compared your method to others (for single cell seq) present on the market repeatedly saying that they are expensive and that they rely on an inefficient adaptor ligation step and so on (page 824). There are several inaccuracies in this statement. First, you can´t compare your method to those because yours is not designed for single cells. Second, it´s absolutely not true that all the methods rely on the (classic, ligase-based) adaptor ligation. Nextera (Illumina) and our recent method (Picelli et al., Genome Res 2014) don´t and they are efficient with ng (Nextera) or sub-pg (ours but also Adey et al., 2010) amounts of input DNA. And in the “Discussion” at the end of page 825 you refer to Ramsköld et al. (Nat Biotech 2012, ref #30) which is NOT based on any ligase but on the first Nextera kit from Illumina! Besides the cost of Smart-seq2+home-made Tn5 is 10-15 euros, comparable to the cost for your library prep.

This comment encompasses many different aspects:

While it is true that CATS was not specifically applied for single cell analysis yet, we definitely can compare CATS with the methods for single-cell RNA-seq.

Thus, any NGS library prep method can be subdivided into: (1) RNA/DNA sample pre-amplification/enrichment step (e.g. SMART enriches for mRNA, random priming can amplify RNA and DNA on whole-genome level, etc) and (2) construction of NGS-platform-specific library. The pre-amplification/enrichment step (#1) may not be necessary if you have enough input material. (also pre-amplification of very short or degraded RNA and DNA such as from blood plasma is not possible). There are 3 general ways to perform step (#2), which all have in common that adapters of known sequences are attached to random fragments of unknown sequences:

(a) Adaptors ligation,
(b) Taqmentation (Tn5)
(c) CATS.

So, in principle, one can substitute tagmentation with fragmentation + CATS (in fact, it could increase the complexity of the final library and be more cheap/fast). Therefore, CATS is a suitable step (#2) during RNA/DNA-seq from single cells as well, provided that whole-genome pre-amplification of the low RNA/DNA input is successfully done by other means (e.g. random priming, SMARTer, etc).

As stated, our goal was a protocol that requires the smallest possible amount of input material at the start of the actual library construction. Since a single cell contains approx. 10-30 pg of total RNA, CATS can be applied directly after fragmentation w/o preliminary whole-transcirptome pre-amplification. Indeed, we have shown in the paper that 5 pg of 22 nt RNA gives a clean library.

About pricing: Commercial kits are expensive mainly due to the fact that they include compensations for significant R&D expenses and requires certain ROI. Therefore, almost any home-made kit will cost drastically less. However, to obtain Tn5 in-house one need to produce and purify it from mammalian cells, if we understood correctly? While this might be possible at some institutions, CATS would be a simpler and a cheaper way where this is not possible. Or, is there is already a cheap commercial provider of Tn5?

About recently emerged tagmentation technique: Back at the end of 2013 when we were preparing the manuscript, the Tn5 method was only available as a part of a single-on-the-market Nextera kit. Albeit is definitely very elegant and promising technique, to our knowledge it is still not widely applied. Therefore, our statement that the widely used methods for construction of NGS-platform-specific library are based on adaptors-ligation was correct.

Finally [Ramsköld et al. // Nat Biotech 2012] describes utilization of Clontech SMARTer kit with adaptors-ligation step besides the utilization of Nextera taqmentation step – “We used the amplified cDNA to construct standard Illumina sequencing libraries using either Covaris shearing followed by ligation of adaptors (PE) or Tn5-mediated 'tagmentation' using the Nextera technology (Tn5)”. So it was cited correctly.

[HeidelbergScience]

8 - in the discussion on page 825 in the same sentence there are several inaccuracies (a record!). It says that “(Nextera) requires at least 50 ng of DNA and, apparently, is restricted to the long DNA molecules. The full capacity of the tagmentation technique for DNA library prep is yet to be tested and compared with other methods”. First: the DNA Nextera XT kit is specifically designed to start from 1 ng input DNA (the old Nextera kit was using 50 ng). We have also shown in Picelli et al., Gen Res 2014 that you need as little as 0.1 pg DNA, but you should have just read Adey et al. 2010. Second: the tagmentation is NOT restricted to long molecules. In fact Adey and Shendure (the original Genome Biol 2010 paper where they describe the method) say that molecules as short as ca. 35 bp can be tagmented. Third, in the same paper they also compare the method to other standard fragmentation methods, showing that the Tn5 has just a weak preference for cutting the DNA at specific sites. Additionally there are also other papers on bisulfite-converted DNA prepped with the Tn5 (Adey et al. Genome Res 2012)…and even one from your Institution (!!!), Wang et al (Nat Prot 2013). So the Tn5-based approach is a viable option for exactly everything you claim not be good for.

At the time of the preparation of our manuscript we did not found scientific reports describing the application of the DNA Nextera XT kit. Isn’t it quite new? The manual of DNA Nextera kit stated that DNA amount should be not less than 50 ng and the length >2000 bp. So, we suppose that the statement in the paper was correct, albeit already outdated.

Although we cited only one paper on Tn5, our statement that “The full capacity of the tagmentation technique for DNA library prep is yet to be tested and compared with other methods” is correct because none of the papers described application Tn5 for DNA-seq of low amounts of fragmented circulating DNA.

Importantly, Tn5-based method are apparently restricted to dsDNA of >300 bp (inferred form Nextera XT manual), and might not be efficient for very fragmented (<150 bp) circulating DNA. Again, we are not claiming that it is impossible; we just saying that “it has to be tested and compared”. Despite the fact that tagmentation may occur on short (<150 bp) dsDNA, the complexity of such libraries has to be demonstrated.

Finally, the library preparation workflow of the published Tn5 methods for bisilfiteDNA-seq is significantly more labor and (at the moment) cost intensive as compared to CATS. However, we certainly agree that tagmentation is a very elegant and promising method, especially as compared to adaptors-ligation.

[HeidelbergScience]

9 - You also state (claim 2 at the end of page 824) that there are no reports of “strand-specific mRNA transcriptome from 1 ng of polyA enriched RNA”, which is obviously inaccurate. Clontech has a protocol for FFPE samples where it couples Ribozero to a stranded SMARTer protocol and starts from as little as 10 ng of degraded TOTAL RNA (designed for FFPE samples), with no column purifications, fragmentation or other preparation steps needed. And 10 ng of tot RNA are in the same order of magnitude as 1 ng of polyA RNA you use in the paper.

Our statement is correct, because Ribozero-treated RNA and polyA-enriched RNA is not the same. The paper underlying the stranded RNA-seq kit from Clontech was cited in our paper as well [Langevin et al, 2013 RNA Biol].

[HeidelbergScience]

10 - Regarding the circulating DNA in the “Discussion” section. It is stated that the Thruplex kit (Rubicon Gen) is not capable to generate libraries from lower quantity of DNA. In principle this is correct, but you forgot to mention that the Picoplex (same company) allows the sequencing of even single CTCs.

Almost any library generation method, including common adaptors-ligation kits, would allow sequencing of a single-cell DNA provided the whole-genome enrichment step is done successfully and in a complexity-conserving manner. As pointed out already above, we have developed CATS as a way to construct NGS-platform-specific libraries that requires the smallest possible amount of input material at the start of the actual library construction as compared to other methods. To our knowledge, Thruplex technology does not allow DNA-seq from single cell without whole-genome pre-amplification. Also a new (launched in Feb 2014) single Cell Library Preparation for Illumina PicoPLEX™ DNA-seq kit contains the whole-genome pre-amplification step.

[HeidelbergScience]

11 - You also claim that your method is better for sequencing circulating DNA compared to Tam-Seq because you sequence the whole genome and not only selected loci. However, the sotry is not that simple: I cite from the original Tam-Seq paper (Forshew et al., Sci Transl Med, 2012): “This generates a large amount of data on genomic regions that do not, at present, inform clinical decisions. Moreover, the depth of coverage for clinically significant loci is not sufficient to detect changes that occur at low frequency (<5%). Such approaches have recently been complemented by methods for examination of individual amplicons at great depth”. If just sequencing the whole genome would be that informative and cheap don´t you think it would have already been done?

That most regions in the human genome are not very informative in terms of clinically relevant loci is well-known fact, we appreciate the useful citation supplied. Moreover your statement is absolutely true when performing a whole-genome sequencing experiment to study well-known disease-associated loci in well characterized material types, for example the most commonly mutated regions in certain tumors, etc.

TAM-Seq works with low amounts of input material due to the efficiency of the PCR reaction, but coming with the price that one can only obtain information about those specific loci. While this is very successful and wanted in certain types of experiments/studies, it might not be suitable for others. For example, it could lead to considerable risks to miss important information (panel bias) if an informative region was not previously recognized as such and is not included as a target region, or if the amplicons do not include all of the relevant nucleotides due to primer design restrictions.

Since circulating DNA properties (origin, fragment sizes, etc.) are quite different from those of the cellular DNA that is usually studied, one cannot yet know if the informative regions are identical. For example, the mere presence of a fragment from an otherwise “uninteresting” region of the genome could prove to highly informative.

With very low input requirements CATS enables to study the whole genome if a researcher wants to do so for reasons of her/his own, while not being restricted to certain pre-defined regions. Many researches do not work in a clinical or human context and/or work with input materials whose properties are not well characterized (such as nucleic acids from plasma or other non-standard sources) and thus do not know the loci that are relevant to their respective contexts. For example, one could explore and identify relevant loci with CATS and perform TAM-Seq on the identified regions.

Another obstacle to using amplicon-based techniques is the fact that they require fragments which are large enough for both PCR primer sites to be present, usually well over 100 bp . We find the majority of circulating DNA fragments is < 100 bp, and amplicon-based technologies do not perform well or at all.

[HeidelbergScience]

12 - It says in a previous post that “Under conditions of the described protocol (e.g. no Mn2+ ions), the terminal transferase activity of the RT enzyme is very limited. Most likely, it only adds 1 nucleotide to the 3'-terminus of the first cDNA strand before template switch occurs”. Sorry again, but we have reported (Nat Meth 2013, Suppl Info) that manganese chloride is NOT necessary for the template switch reaction to occur. Besides, even in the original SMARTer paper (Zhu et al., Biotechniques 2001) manganese chloride was not even mentioned.

Interestingly, our data on the contrary indicates that Mn2+ enhances template switching event, presumably by enhancing the dC-terminal transferases activity on MMLV. However, at the same time it also dramatically increased the occurrence of “empty” DNA libraries because RT reverse primer was also highly polyC-tailed. Indeed, it a well-known fact that Mn2+ enhances the terminal dC-transferase activity of MMLV RT [e.g. Schmidt WM and Mueller MW // Nucl Acids Res 1999 showed that after addition of Mn2+ the number of terminally added nucleotides increased from 1 to 3+)

Unlike in CATS, in SMART-seq the TS at the end of the RNA templates may not be a rate limiting step; since during SMART the most template switching events are likely to occur before the MMLV RT reaches the end of the mRNA (and starts to add dCs). Albeit only a speculation, but this could be the reason why you did not observe the increase after Mn2+ addition.

[Simone78]

Secondly, in the main text and supplementary material in [Picelli et al, Nat Met // 2013] we did not find any written comments on the different TS capacities of various RT enzymes. Albeit from the supplementary table it is indeed possible to infer that both Smartscribe and SSRTII secures much higher yield of final DNA library as compared to SSRTIII, there is no information about other three enzymes tested in our paper.

We did not investigate all the enzymes systematically, although in "Suppl table 1" we reported trials with SSRTII, SSRTIII, SmartScribe, Revertaid H-, Revertaid Premium and Maxima H-. Both from the table (difficult to find, I agree!) and other papers is clear that the TS activity, measured by looking at the cDNA yield, must be negligible. A recent example where SSRT II was compared to III can be found in a recent paper from the Linnarsson group (Zajac P et al., PLoS One 2013). The reason for al the discrepancies in the literature is, however, still a mistery to me...

[Simone78]

Also, in [Picelli et al, 2013] maintext we found one solid statement that “exchanging only a single guanylate for a locked nucleic acid (LNA)11 guanylate at the TSO 3′ end (rGrG+G) led to a twofold increase in cDNA yield relative to that obtained with the SMARTer IIA oligo”. Could you tell how big was the drop in library yield when you used a N-base at the end, as you stated above?

I can´t remember this detail off the top of my head, but I would say just slightly worse (a noticeable difference but not huge). All comparisons (Smarter2 vs the Smarter kit) can be found in the Suppl material of the Nat Methods paper.
Suppl table 4 has a list of all the comparisons with details in what they are different between each other.
Suppl table 3 has the detail of all the single cells analyzed with each protocol (sheet A) as well as the statistical analysis of the different variables (sheet B), where we looked not only at the TSO but also PCR enzyme, additives, etc etc.
Suppl Figure 1 and 2 give you an idea of the difference in the sensitivity and variability of different protocols.
In short, the rGrG+G oligo is better than rGrG+N, which is anyway better than the TSO from the kit.

[Simone78]

One can use 10 ng of total RNA input, enrich it for mRNA via poly(dT) magnetic beads and fragment with Mg2+, yielding approx. 100-300 pg of 20-100 bp RNA in 40 µl eluate. The important thing here is to add 10 µg of glycogen as a co-precipitant during clean-up step (with miRNAeasy kit). In our hands, the whole procedure of sample preparation (before polyA-tailing) takes about 1 hour. Subsequently one could set-up a poly(A) reaction in 50 µl and, than concentrate the whole 50 µl (e.g. via Zymo columns or EtOH precipitation). Even 10 pg of fragmented RNA is already enough for CATS (the protocol posted on this forum) to generate high complexity libraries for mRNA-seq. There are also many other options to fragment RNA (including thermosensitive RNAses) w/o the need to subsequently purify and concentrate the sample.

However, if we speak about mRNA-seq from ultra-low (1-100) number of cells, then SMART-seq is probably the most convenient way (and Ribozero would not be even necessary). However, most researchers are working with much higher number of cells (e.g. growing on 96 - 24well plates), from where obtaining 100-1000 ng of RNA is not a problem. After ~30 min procedure of poly(A)-enrichment, one can get 3 – 30 ng of mRNA in 40 µl eluate, and run CATS even without a need to concentrate the polyadenylated product before RT. Also, unlike SMART-seq, CATS gives (1) strand-specific information about mRNA and (2) has even coverage along all mRNAs. While:

(1) SMART-based mRNA-seq is not strand specific.

(2) with SMART-seq 5’-proximal and 3’-proximal parts of mRNAs are likely to be significantly underrepresented due to the inevitable premature template switching and taqmentation bias. Please correct us if we are wrong.

(3) SMART-seq is limited only to mRNA-sequencing; while CATS allows any RNA-seq, including small (20-200nt) RNA, like RIP-samples, miRNA, piRNA etc, and also any DNA-seq. So it is a universal protocol.

(4) SMART-seq would actually require more efforts because “RT and template switch” there is used only to generate and pre-amplify long cDNAs from mRNA. The library preparation itself occurs afterwards via fragmentation/adaptors ligation or taqmentation and further pre-amplification + purification. It is much easier to do mRNA enrichment (30 min), fragmentation/cleanup (20 min) and CATS (4-5 hours total, 20 min hands-on time).

To summarize, if you have a few cells and require only mRNA-seq than SMART-seq is the probably the best option. However, one can still convert mRNA from a single-cell into cDNA using poly(dT) primers, and run CATS after genome-wide DNA pre-amplification till hundred picograms.

If you would use Ribozero + Smarter (the STRANDED kit, maybe I should have specified it. I thought it was clear from the context but if you are not familiar with the Clontech kits it might have been confusing, sorry) then what you claim at point 1 and 3 above is wrong. Of course, Smart-seq2 is unfortunately still limited to mRNA only (and some additional other bias and problems). About point 4: I didn´t count exactly the mins you need to do a plate with Smart-seq2 but I don´t think is so far way from your protocol in terms of hands-on time. Every step can be easily done on the Bravo and almost all the master mixes can be prepared even weeks in advance and thawed just before adding them to the sample.
About point 2: in our Nat Methods paper (tagmentation done with Nextera) the coverage at the 3´and 5´is analysed in Suppl Fig 3E, 8 and 9 (as well as in Figure 2 of the main text). You will notice that there is no drop at the 3´and also a good coverage with only a slight drop at the 5´. Explanation: at both ends we have some "extra template" for the transposase to cut, i.e. the long oligo dT and the TSO. It means that even if the first 10, 20 or 30 nucleotides are "lost" with the cutting the transcript is not affected. In our recent Genome Res paper we saw the same but we didn´t report it since the library was done again with Smart-seq2 and there was no difference in performance between Nextera and our transposase in all the things we looked at.

[HeidelbergScience]

If you would use Ribozero + Smarter (the STRANDED kit, maybe I should have specified it. I thought it was clear from the context but if you are not familiar with the Clontech kits it might have been confusing, sorry) then what you claim at point 1 and 3 above is wrong. Of course, Smart-seq2 is unfortunately still limited to mRNA only (and some additional other bias and problems). About point 4: I didn´t count exactly the mins you need to do a plate with Smart-seq2 but I don´t think is so far way from your protocol in terms of hands-on time. Every step can be easily done on the Bravo and almost all the master mixes can be prepared even weeks in advance and thawed just before adding them to the sample.
About point 2: in our Nat Methods paper (tagmentation done with Nextera) the coverage at the 3´and 5´is analysed in Suppl Fig 3E, 8 and 9 (as well as in Figure 2 of the main text). You will notice that there is no drop at the 3´and also a good coverage with only a slight drop at the 5´. Explanation: at both ends we have some "extra template" for the transposase to cut, i.e. the long oligo dT and the TSO. It means that even if the first 10, 20 or 30 nucleotides are "lost" with the cutting the transcript is not affected. In our recent Genome Res paper we saw the same but we didn´t report it since the library was done again with Smart-seq2 and there was no difference in performance between Nextera and our transposase in all the things we looked at.

We know all Clontech kits of course, but we thought you meant SMARTer Universal Low Input RNA Kit and your-own SMART-seq2, as you wrote “10 ng + SMARTer (or SMART-seq2)”.

For SMARTer Stranded RNA-Seq Kit points 1, 3 (partly) and 4 definitely cannot be applied; however the most important question is - what is the complexity of the final library. In fact even conventional ligation-based methods may generate the library from 5 ng RNA or DNA (or even below). The question is – how many different fragments they would capture, and what would be the % of PCR duplicates.

SMARTER stranded kit is based on random N6 priming, and therefore: restricted to only long RNAs. It certainly will not capture short RNAs (miRNA, piRNA) and have troubles with RIP samples. Furthermore, random priming RT is inefficient on DNA templates, since DNA/DNA binding is much weaker than RNA/DNA.

The fundamental advantage of poly(A)/(dA) tailing is that even 1 molecule in the solution will be tailed (there is no limit of "efficient concentration"), while the use of long (30x) polydT reverse primer secures the efficient capture of highly diluted molecules for the RT.

Also, good to know that the SMART-seq2 has even representation over the mRNA. It remains the great option for single-cell mRNA sequencing indeed.

[Simone78]

However, to obtain Tn5 in-house one need to produce and purify it from mammalian cells, if we understood correctly? While this might be possible at some institutions, CATS would be a simpler and a cheaper way where this is not possible. Or, is there is already a cheap commercial provider of Tn5?

We made available the pTBX1-Tn5 plasmid to everybody and it can be purchased from Addgene for 65 USD. It can be easily produced in E.coli (C3013 strain). 1 litre of culture will make as much tn5 as you need for probably half a million single cell experiments.

[Simone78]

Unlike in CATS, in SMART-seq the TS at the end of the RNA templates may not be a rate limiting step; since during SMART the most template switching events are likely to occur before the MMLV RT reaches the end of the mRNA (and starts to add dCs). Albeit only a speculation, but this could be the reason why you did not observe the increase after Mn2+ addition.

exactly! unfortunately just an UNSUPPORTED speculation...however we also tried to add the MnCl2 at different times after the RT was initiated. Result: the sooner the MnCl2 was added the lower the final yield up to a point that the yield was zero when MnCl2 was added in the beginning. Of course this might also be due to some oxidation/interference with some other component in the reaction.
Besides, if we had so much "premature" TS then we wouldn´t observe an almost even coverage of the transcript body or of the longest transcripts as we, in fact, do (it´s actually one of the major improvements over the Clontech kit...).

[Simone78]

Our statement is correct, because Ribozero-treated RNA and polyA-enriched RNA is not the same. The paper underlying the stranded RNA-seq kit from Clontech was cited in our paper as well [Langevin et al, 2013 RNA Biol].

It was just to give an idea of the amounts we were talking about. ASSUMING 10 pg TOT RNA/cell AND ASSUMING that 1-5% of the cell RNA is mRNA, then 1 ng mRNA corresponds APPROXIMATELY to 200 pg - 1 ng TOT RNA. So the inputs to start with the different protocols are in the same order of magnitude.

[Simone78]

At the time of the preparation of our manuscript we did not found scientific reports describing the application of the DNA Nextera XT kit. Isn’t it quite new? The manual of DNA Nextera kit stated that DNA amount should be not less than 50 ng and the length >2000 bp. So, we suppose that the statement in the paper was correct, albeit already outdated.

I just randomly googled "Nextera XT + launch + date" and I got this:

https://www.genomeweb.com/sequencing/new-products-illuminas-nextera-xt-kits-agilents-haloplex-system-ion-torrent-kits

so, already in mid-2012 the Nextera XT was available/going to be available. in fact, when we first tried the XT kit and compared to our first version of home-made tn5 was mid-2013 for sure...but this is not so important.
The 50 ng and 2000 bp are meant as the "golden standard". If you, for example, tagment a library of 1000 bp (avg size) you´ll get usable data anyway but probably will have a poor coverage at the 5´end of the transcripts, especially the long ones. It depends what you are looking for with your experiments, of course.

Although we cited only one paper on Tn5, our statement that “The full capacity of the tagmentation technique for DNA library prep is yet to be tested and compared with other methods” is correct because none of the papers described application Tn5 for DNA-seq of low amounts of fragmented circulating DNA.

Importantly, Tn5-based method are apparently restricted to dsDNA of >300 bp (inferred form Nextera XT manual), and might not be efficient for very fragmented (<150 bp) circulating DNA. Again, we are not claiming that it is impossible; we just saying that “it has to be tested and compared”. Despite the fact that tagmentation may occur on short (<150 bp) dsDNA, the complexity of such libraries has to be demonstrated.

Yes, the Nextera or Nextera XT manuals can tell you whatever they want...but doesn´t necessarily means that it´s true! If you look, again, to Adey et al. (2010) you will see that even fragments down to 40 bp can be tagmented (what we also observed with our Tn5). Of course Adey et al. were not working with fragmented DNA but the fact that the tn5 cuts even very short fragments remains. Besides, the transposase is not a "classic" enzyme, so each dimer cuts and ligates DNA only once and then becomes inactive. What we observed is that the cutting efficiency can be increase with additives (PEG), increasing the amount of enzyme, decreasing the amount of DNA and/or extending the incubation time. As we also observed, if you have a cDNA library with a very short avg size after Smart-seq2 (derived from a very degraded sample) you will get a very beautiful peak after tagmentation+PCR...but when you´ll analyze the data it will look awful. Translation: the tn5, especially when added in excess, can cut virtually ANYTHING that is double-stranded (and the reaction is driven to completion). The complexity reflects the initial quality of your sample rather than the efficiency of the tagmentation reaction alone. Or, at least, this is what we concluded looking at the data.

Finally, the library preparation workflow of the published Tn5 methods for bisilfiteDNA-seq is significantly more labor and (at the moment) cost intensive as compared to CATS. However, we certainly agree that tagmentation is a very elegant and promising method, especially as compared to adaptors-ligation.

not really, just the oligo replacement step. Once you can make the Tn5 yourself it´s not big deal playing with the adaptors. About the costs you were right but it´s not true anymore if one can make his own tn5.

All in all, I really appreciate your comments and explanations! I´ll have them with me when I will read the paper again! I don´t have time to go through all your answers to my comments now but I think they addressed most of my doubts (some remain...). And, as I said in the beginning: the paper has some interesting ideas and interesting possible applications!